Shree Ganesh Remedies Ltd Fair Value
SGRL · Healthcare · Current price ₹635.8
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹154 | 16% ROE fading to 12% over ~10 yrs, on ₹127 book |
| Relative P/E | ₹973 | EPS × 44.4 peer-median P/E |
| Graham floor | ₹250 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is Shree Ganesh Remedies Ltd undervalued?
DocStoX estimates the fair value of Shree Ganesh Remedies Ltd at ₹399 per share, versus the current market price of ₹636. That puts the stock about -37.2% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹154), Relative P/E (₹973), Graham floor (₹250). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹154 (bear) to ₹399 (base) to ₹973 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on Shree Ganesh Remedies Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.